Jennifer Lee Caswell-Jin
2 clinical trials · Sponsor
◉ Watch Jennifer Lee Caswell-Jin
| Record | Firm | Date |
|---|---|---|
| Umbrella Trial of Subtype-Targeted Therapies in ER+/HER2- Breast Cancer (NCT05101564) | Jennifer Lee Caswell-Jin | 2023-03-20 |
| Study of Infigratinib in Combination With Tamoxifen in Hormone Receptor Positive, HER2 Negative, FGFR Altered Advanced Breast Cancer (NCT04504331) | Jennifer Lee Caswell-Jin | 2020-10-13 |
Track Jennifer Lee Caswell-Jin automatically
Every clearance here is in the API, with alerts when new ones post.